AIM ImmunoTech Inc.
AMEX:AIM
0.449 (USD) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.202 | 0.141 | 0.135 | 0.163 | 0.14 | 0.367 | 0.437 | 0.092 | 0.133 | 0.197 | 0.15 | 0.213 | 0.161 | 0.135 | 0.111 | 0.265 | 1.059 | 0.933 | 1.083 | 1.229 | 0.657 | 0.341 | 0.39 | 0.788 | 0.7 | 0.4 | 0.3 | 0.1 | 3 |
| Cost of Revenue
| 0.042 | 19.923 | 0.85 | 0.806 | 0.893 | 0.884 | 1.183 | 1.108 | 1.598 | 1.251 | 1.234 | 1.989 | 1.043 | 1.341 | 0.584 | 0.798 | 0.93 | 1.275 | 0.391 | 2.112 | 0.502 | 0 | 0 | -0.487 | -0.3 | -0.3 | -0.2 | -0.1 | -0.3 |
| Gross Profit
| 0.16 | -19.782 | -0.715 | -0.643 | -0.753 | -0.517 | -0.746 | -1.016 | -1.465 | -1.054 | -1.084 | -1.776 | -0.882 | -1.206 | -0.473 | -0.533 | 0.129 | -0.342 | 0.692 | -0.883 | 0.155 | 0.341 | 0.39 | 1.275 | 1 | 0.7 | 0.5 | 0.2 | 3.3 |
| Gross Profit Ratio
| 0.792 | -140.298 | -5.296 | -3.945 | -5.379 | -1.409 | -1.707 | -11.043 | -11.015 | -5.35 | -7.227 | -8.338 | -5.478 | -8.933 | -4.261 | -2.011 | 0.122 | -0.367 | 0.639 | -0.718 | 0.236 | 1 | 1 | 1.618 | 1.429 | 1.75 | 1.667 | 2 | 1.1 |
| Reseach & Development Expenses
| 10.939 | 6.99 | 7.672 | 5.72 | 4.651 | 4.778 | 4.098 | 5.107 | 8.038 | 8.988 | 8.36 | 9.508 | 6.722 | 7.613 | 6.995 | 5.8 | 10.444 | 10.127 | 5.144 | 3.842 | 3.15 | 4.946 | 5.78 | 6.136 | 4.7 | 4.6 | 3.2 | 1.9 | 0 |
| General & Administrative Expenses
| 21.012 | 13.074 | 8.672 | 8.654 | 7.039 | 6.201 | 6.572 | 7.681 | 7.147 | 9.057 | 7.723 | 9.056 | 6.691 | 7.568 | 5.796 | 0 | 8.974 | 8.225 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0.623 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 21.635 | 13.074 | 8.672 | 8.654 | 7.039 | 6.201 | 6.572 | 7.681 | 7.147 | 9.057 | 7.723 | 9.056 | 6.691 | 7.568 | 5.796 | 6.478 | 8.974 | 8.225 | 5.187 | 6.164 | 4.257 | 2.015 | 3.412 | 3.695 | 5.6 | 3 | 3.5 | 3 | 4 |
| Other Expenses
| -0.498 | 1.49 | 2.319 | 1.186 | 0.866 | 0.277 | 3.208 | 2.87 | 1.374 | 1.126 | 0.686 | 1.328 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.487 | 0.3 | 0.3 | 0.2 | 0.1 | 0.3 |
| Operating Expenses
| 32.076 | 20.064 | 16.344 | 14.374 | 11.69 | 10.979 | 10.67 | 12.788 | 15.185 | 18.045 | 16.083 | 18.564 | 13.413 | 15.181 | 12.791 | 12.278 | 19.418 | 18.352 | 10.331 | 10.006 | 7.407 | 6.961 | 9.192 | 10.318 | 10.6 | 7.9 | 6.9 | 5 | 4.3 |
| Operating Income
| -31.916 | -19.923 | -18.838 | -15.152 | -12.443 | -11.496 | -11.416 | -13.804 | -16.65 | -19.099 | -17.167 | -20.34 | -14.295 | -16.387 | -13.264 | -12.811 | -19.289 | -18.694 | -9.639 | -10.889 | -7.252 | -6.62 | -8.802 | -9.043 | -9.6 | -7.2 | -6.4 | -4.8 | -1 |
| Operating Income Ratio
| -158 | -141.298 | -139.541 | -92.957 | -88.879 | -31.324 | -26.124 | -150.043 | -125.188 | -96.949 | -114.447 | -95.493 | -88.789 | -121.385 | -119.495 | -48.343 | -18.214 | -20.036 | -8.9 | -8.86 | -11.038 | -19.413 | -22.569 | -11.476 | -13.714 | -18 | -21.333 | -48 | -0.333 |
| Total Other Income Expenses Net
| 2.954 | 0.478 | -0.289 | 0.752 | 2.91 | 2.139 | 3.208 | 6.173 | 1.059 | 0.995 | 0.167 | 1.413 | 4.697 | 0.879 | -0.174 | 0 | 1.15 | -0.705 | 0 | -12.916 | -7.345 | -0.907 | -0.565 | -0.081 | 0 | -0.2 | 0.3 | 0.3 | 0.1 |
| Income Before Tax
| -28.962 | -19.445 | -19.127 | -14.4 | -9.533 | -9.813 | -8.259 | -7.502 | -15.23 | -17.45 | -16.225 | -17.354 | -9.015 | -13.136 | -13.438 | 0 | -18.139 | -19.399 | 0 | -23.805 | -14.597 | -7.527 | -9.367 | -9.124 | 0 | -7.4 | -6.1 | -4.5 | -0.9 |
| Income Before Tax Ratio
| -143.376 | -137.908 | -141.681 | -88.344 | -68.093 | -26.738 | -18.899 | -81.543 | -114.511 | -88.579 | -108.167 | -81.474 | -55.994 | -97.304 | -121.063 | 0 | -17.128 | -20.792 | 0 | -19.369 | -22.218 | -22.073 | -24.018 | -11.579 | 0 | -18.5 | -20.333 | -45 | -0.3 |
| Income Tax Expense
| 0 | 1.641 | 2.386 | 1.858 | 1.293 | 2.185 | 3.347 | 0.134 | 0.003 | 0.011 | 0.016 | 0.024 | -5.28 | -3.251 | 0 | -0.592 | 0 | 0 | 3.574 | 12.878 | 7.518 | -0.666 | -0.284 | -0.491 | -0.4 | 0.1 | -0.3 | -0.2 | 0.8 |
| Net Income
| -28.962 | -21.086 | -21.513 | -16.258 | -10.826 | -9.813 | -8.259 | -7.502 | -15.23 | -17.45 | -16.225 | -17.354 | -9.015 | -13.136 | -13.438 | -12.219 | -18.139 | -19.399 | -13.213 | -24.14 | -14.77 | -7.424 | -9.083 | -8.552 | -9.2 | -7.3 | -6.1 | -4.6 | -1.8 |
| Net Income Ratio
| -143.376 | -149.546 | -159.356 | -99.742 | -77.329 | -26.738 | -18.899 | -81.543 | -114.511 | -88.579 | -108.167 | -81.474 | -55.994 | -97.304 | -121.063 | -46.109 | -17.128 | -20.792 | -12.2 | -19.642 | -22.481 | -21.771 | -23.29 | -10.853 | -13.143 | -18.25 | -20.333 | -46 | -0.6 |
| EPS
| -0.6 | -0.44 | -0.45 | -0.51 | -2.97 | -9.77 | -12.67 | -15.13 | -34.05 | -48.93 | -51.2 | -64.98 | -35.15 | -51.75 | -64.79 | -85.86 | -133.32 | -165.7 | -135.53 | -282.13 | -221.34 | -122.17 | -152.58 | -154.37 | -184.14 | -168.96 | -184.8 | -154.53 | -57.03 |
| EPS Diluted
| -0.6 | -0.44 | -0.45 | -0.51 | -2.97 | -9.77 | -12.67 | -15.13 | -34.05 | -48.93 | -51.2 | -64.98 | -35.15 | -51.75 | -64.79 | -85.86 | -133.32 | -165.7 | -135.53 | -282.13 | -221.34 | -122.17 | -152.58 | -154.37 | -184.14 | -168.96 | -184.8 | -154.53 | -57.03 |
| EBITDA
| -31.678 | -17.548 | -13.965 | -12.879 | -10.696 | -10.295 | -7.109 | -12.372 | -15.096 | -17.292 | -15.509 | -18.06 | -18.362 | -16.486 | -12.283 | -12.095 | -18.572 | -17.714 | -5.227 | 14.637 | 7.64 | -6.886 | -8.278 | -8.475 | -9.3 | -6.7 | -6.5 | -5 | -0.8 |
| EBITDA Ratio
| -156.822 | -124.454 | -103.444 | -79.012 | -76.4 | -28.052 | -16.268 | -134.478 | -113.504 | -87.777 | -103.393 | -84.789 | -114.05 | -122.119 | -110.658 | -45.642 | -17.537 | -18.986 | -4.826 | 11.91 | 11.629 | -20.194 | -21.226 | -10.755 | -13.286 | -16.75 | -21.667 | -50 | -0.267 |